Technology Assisted Treatment for Trichotillomania

This study is testing two digital health tools for adults with trichotillomania (TTM), which is recurrent hair pulling. You could be eligible if you are 18 or older, speak English, and have TTM primarily involving hair pulling above the neck (like scalp, eyebrows, or eyelashes). One group will use the Keen2 bracelet, which vibrates when it detects hair pulling, along with the Keen2 app for behavior therapy. The other group will use a non-vibrating reminder bracelet and a Health Reminders App that logs your daily activities and offers general health tips. The main goal is to see how much TTM symptoms improve after 8 weeks, as rated by a clinician. The study aims to enroll 90 participants, but its current status is unclear.

Study design
This is an interventional study where 90 participants will be randomly assigned (50/50 chance) to one of two groups for 8 weeks.
What's involved
Participants will use a digital health intervention (either the Keen2 bracelet and app or a reminder bracelet and Health Reminders App) for 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint for measuring symptom severity is at 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05118633

Technology Assisted Treatment for Trichotillomania

Recruiting
NAAges 18+InterventionalTreatment
HabitAware Inc.
~90 participants
Updated 2026-06-02 on ClinicalTrials.gov
What's tested:Keen2 braceletReminder braceletKeen2 appHealth Reminders App

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinician-rated trichotillomania (TTM) symptom severity at endpoint (week 8)
Measured over Eight weeks
Trichotillomania
1 sites across 1 states
Ohio1

Opens a ready-to-send draft in your own email app — review before sending.

  • Clinician-rated trichotillomania (TTM) symptom severity at endpoint (week 8)Eight weeks

    Scores on the NIMH Trichotilomania Severity Scale (NIMH-TSS), a clinician-administered assessment of TTM symptom severity, will be compared across conditions at endpoint (week 8), controlling for baseline severity. The NIMH-TSS is a 5-item clinician rated measure of TTM severity ranging from 0-25, with higher scores indicating more severe symptoms.